Vimarsana
Biggest News Aggregation in the World

Page 20 - Double Blind Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Double Blind Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Double Blind Study Today - Breaking & Trending Today

Post-Bariatric Surgery Weight Loss Improves Thyroid Function - Vimarsana News

Post-Bariatric Surgery Weight Loss Improves Thyroid Function

After bariatric surgery, people with obesity and normal thyroid function who lost more weight were more likely to have improved thyroid function.

Prognosis of Polyarteritis Nodosa: What Are the Predictors? - Vimarsana News

Prognosis of Polyarteritis Nodosa: What Are the Predictors?

Constitutional symptoms were significantly more common in systemic vs cutaneous disease.

The Ghost Research Haunting Nordic Medical Trials - Vimarsana News

The Ghost Research Haunting Nordic Medical Trials

The results of hundreds of clinical trials in Nordic countries have never been made public. Experts say it's a global problem.

India Pharma Companies Develop Versions Of Wegovy to Get in on Weight-loss Windfall - Vimarsana News

India Pharma Companies Develop Versions Of Wegovy to Get in on Weight-loss Windfall

Indian drugmakers aiming to grab a slice of the burgeoning weight-loss treatment sales pie, both at home and abroad, have begun developing their own versions of Novo...

Nemolizumab Being Reviewed for AD, Prurigo Nodularis - Vimarsana News

Nemolizumab Being Reviewed for AD, Prurigo Nodularis

For prurigo nodularis, the FDA has granted nemolizumab, a monoclonal antibody designed to inhibit interleukin-31 signaling, priority review.